P. G. Smith and R. Bradley, Bovine spongiform encephalopathy (BSE) and its epidemiology, British Medical Bulletin, vol.66, issue.1, pp.185-198, 2003.
DOI : 10.1093/bmb/66.1.185
URL : https://academic.oup.com/bmb/article-pdf/66/1/185/800902/185.pdf

C. C. Chen and Y. Wang, Estimation of the Exposure of the UK Population to the Bovine Spongiform Encephalopathy Agent through Dietary Intake During the Period 1980 to 1996, PLoS ONE, vol.100, issue.8, p.94020, 1980.
DOI : 10.1371/journal.pone.0094020.t004

P. J. Urwin, J. M. Mackenzie, C. A. Llewelyn, R. G. Will, and P. Hewitt, Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study, Vox Sanguinis, vol.20, issue.Suppl, pp.310-316, 2016.
DOI : 10.3201/eid2001.130353

A. Peden, Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia, Haemophilia, vol.19, issue.2, pp.296-304, 2010.
DOI : 10.1182/blood-2008-04-152520

M. L. Turner and C. A. Ludlam, An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products, British Journal of Haematology, vol.101, issue.Suppl. 1, pp.14-23, 2009.
DOI : 10.1016/S0021-9673(99)00514-2

L. Gregori, Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood, The Lancet, vol.364, issue.9433, pp.529-531, 2004.
DOI : 10.1016/S0140-6736(04)16812-8

O. N. Gill, Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey, BMJ, vol.347, issue.oct15 5, p.5675, 2013.
DOI : 10.1136/bmj.f5675
URL : http://www.bmj.com/content/bmj/347/bmj.f5675.full.pdf

J. Collinge, Kuru in the 21st century???an acquired human prion disease with very long incubation periods, The Lancet, vol.367, issue.9528, pp.2068-2074, 2006.
DOI : 10.1016/S0140-6736(06)68930-7

P. Brown, Iatrogenic Creutzfeldt-Jakob Disease, Final Assessment, Emerging Infectious Diseases, vol.18, issue.6, p.7, 2012.
DOI : 10.3201/eid1806.120116
URL : https://doi.org/10.3201/eid1806.120116

A. Parker, P. Bennett, M. Daraktchiev, and . Sabto, Importation of Plasma as a vCJD Risk Reduction Measure: Reconsideration of 'Acceptable' Source Countries, 2013.

C. I. Lasmezas, Transmission of the BSE Agent to Mice in the Absence of Detectable Abnormal Prion Protein, Science, vol.227, issue.5259, pp.402-405, 1997.
DOI : 10.1038/227680a0

L. Cervenakova, Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy, Transfusion, vol.51, issue.11, pp.1687-1694, 2003.
DOI : 10.1073/pnas.97.18.10168

D. C. Gajdusek, Unconventional viruses and the origin and disappearance of kuru, Science, vol.197, issue.4307, pp.943-960, 1977.
DOI : 10.1126/science.142303

P. Brown, Human spongiform encephalopathy: The national institutes of health series of 300 cases of experimentally transmitted disease, Annals of Neurology, vol.258, issue.5, pp.513-529, 1994.
DOI : 10.1212/WNL.42.2.422

C. I. Lasmezas, BSE transmission to macaques, Nature, vol.381, issue.6585, pp.743-744, 1996.
DOI : 10.1038/381743a0

C. I. Lasmezas, Risk of oral infection with bovine spongiform encephalopathy agent in primates, The Lancet, vol.365, issue.9461, pp.781-783, 2005.
DOI : 10.1016/S0140-6736(05)17985-9

V. A. Berardi, F. Cardone, A. Valanzano, M. Lu, and M. Pocchiari, Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation, Transfusion, vol.6, issue.4, pp.652-658, 2006.
DOI : 10.1016/j.biologicals.2005.01.002

C. Bett, Enhanced neuroinvasion by smaller, soluble prions, Acta Neuropathologica Communications, vol.113, issue.20, pp.32-42, 2017.
DOI : 10.3791/51899
URL : https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0430-z?site=actaneurocomms.biomedcentral.com

A. Link, Innate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein Antigen, The Journal of Immunology, vol.188, issue.8, pp.3724-3733, 2012.
DOI : 10.4049/jimmunol.1103312
URL : http://www.jimmunol.org/content/jimmunol/188/8/3724.full.pdf

C. I. Lasmezas, Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt- Jakob disease: Implications for human health, Proc. Natl Acad. Sci. USA 98, pp.4142-4147, 2001.
DOI : 10.1016/S0140-6736(05)74505-0

D. A. Brown, M. E. Bruce, and J. Fraser, Comparison of the neuropathological characteristics of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in mice, Neuropathology and Applied Neurobiology, vol.20, issue.3, pp.262-272, 2003.
DOI : 10.1016/S0006-8993(98)00833-6

J. Collinge and A. R. Clarke, A General Model of Prion Strains and Their Pathogenicity, Science, vol.313, issue.5794, pp.930-936, 2007.
DOI : 10.1126/science.1131864

J. Lauren, D. A. Gimbel, H. B. Nygaard, J. W. Gilbert, and S. M. Strittmatter, Cellular prion protein mediates impairment of synaptic plasticity by amyloid-?? oligomers, Nature, vol.22, issue.7233, pp.1128-1132, 2009.
DOI : 10.1212/01.WNL.0000130198.72589.69

S. Supattapone and . Biochemistry, What Makes a Prion Infectious?, Science, vol.121, issue.2, pp.1091-1092, 2010.
DOI : 10.1016/j.cell.2005.02.011

A. Bravard, The prion protein is critical for DNA repair and cell survival after genotoxic stress, Nucleic Acids Research, vol.43, issue.2, pp.904-916, 2015.
DOI : 10.1093/nar/gku1342
URL : https://academic.oup.com/nar/article-pdf/43/2/904/17434992/gku1342.pdf

R. Chiesa, Molecular Distinction between Pathogenic and Infectious Properties of the Prion Protein, Journal of Virology, vol.77, issue.13, pp.7611-7622, 2003.
DOI : 10.1128/JVI.77.13.7611-7622.2003

S. Hannaoui, Prion Propagation and Toxicity Occur In Vitro with Two-Phase Kinetics Specific to Strain and Neuronal Type, Journal of Virology, vol.87, issue.5, pp.2535-2548, 2013.
DOI : 10.1128/JVI.03082-12
URL : http://jvi.asm.org/content/87/5/2535.full.pdf

A. G. Timmes, R. A. Moore, E. R. Fischer, and S. A. Priola, Recombinant Prion Protein Refolded with Lipid and RNA Has the Biochemical Hallmarks of a Prion but Lacks In Vivo Infectivity, PLoS ONE, vol.11, issue.7, p.71081, 2013.
DOI : 10.1371/journal.pone.0071081.s004

S. Krasemann, M. Neumann, B. Szalay, C. Stocking, and M. Glatzel, Protease-sensitive prion species in neoplastic spleens of prion-infected mice with uncoupling of PrPSc and prion infectivity, Journal of General Virology, vol.94, issue.Pt_2, pp.453-463, 2013.
DOI : 10.1099/vir.0.045922-0

K. Dobie and R. Barron, Dissociation between Transmissible Spongiform Encephalopathy (TSE) Infectivity and Proteinase K-Resistant PrPSc Levels in Peripheral Tissue from a Murine Transgenic Model of TSE Disease, Journal of Virology, vol.87, issue.10, pp.5895-5903, 2013.
DOI : 10.1128/JVI.03469-12

I. Bouybayoune, Transgenic Fatal Familial Insomnia Mice Indicate Prion Infectivity-Independent Mechanisms of Pathogenesis and Phenotypic Expression of Disease, PLOS Pathogens, vol.299, issue.1, p.1004796, 2015.
DOI : 10.1371/journal.ppat.1004796.s003

J. Greenlee, B. Kunkle, J. D. Smith, and H. Greenlee, Scrapie in Swine: a Diagnostic Challenge, Food Safety, vol.4, issue.4, p.16, 2016.
DOI : 10.14252/foodsafetyfscj.2016019

S. Dudas, Oral transmission of classical BSE to adult cattle, Prion, vol.10, p.118, 2016.

T. Mok, Codon 129, New England Journal of Medicine, vol.376, issue.3, pp.292-294, 2017.
DOI : 10.1056/NEJMc1610003

C. D. Orru, J. M. Wilham, S. Vascellari, A. G. Hughson, and B. Caughey, New generation QuIC assays for prion seeding activity, Prion, vol.6, issue.2, pp.147-152, 2012.
DOI : 10.1371/journal.ppat.1000736
URL : http://www.tandfonline.com/doi/pdf/10.4161/pri.19430?needAccess=true

M. A. Barria, A. Mukherjee, D. Gonzalez-romero, R. Morales, and C. Soto, De Novo Generation of Infectious Prions In Vitro Produces a New Disease Phenotype, PLoS Pathogens, vol.281, issue.5, p.1000421, 2009.
DOI : 10.1371/journal.ppat.1000421.s005

Z. Zhang, De novo generation of infectious prions with bacterially expressed recombinant prion protein, The FASEB Journal, vol.27, issue.12, pp.4768-4775, 2013.
DOI : 10.1096/fj.13-233965
URL : http://www.fasebj.org/content/27/12/4768.full.pdf

M. Klingeborn, B. Race, K. D. Meade-white, and B. Chesebro, Lower specific infectivity of protease-resistant prion protein generated in cell-free reactions, Proc. Natl Acad. Sci. USA, pp.1244-1253, 2011.
DOI : 10.1073/pnas.0702662104

E. Holznagel, Foodborne Transmission of Bovine Spongiform Encephalopathy to Nonhuman Primates, Emerging Infectious Diseases, vol.19, issue.5, pp.712-720, 2013.
DOI : 10.3201/eid1905.120274
URL : https://wwwnc.cdc.gov/eid/article/19/5/pdfs/12-0274.pdf

J. D. Katz and A. H. Ropper, Progressive Necrotic Myelopathy, Archives of Neurology, vol.57, issue.3, pp.355-361, 2000.
DOI : 10.1001/archneur.57.3.355
URL : http://archneur.jamanetwork.com/data/journals/neur/13125/noc8547.pdf

J. B. Cavanagh and B. N. Harding, Pathogenic factors underlying the lesions in Leigh's disease, Brain, vol.117, issue.6, pp.1357-1376, 1994.
DOI : 10.1093/brain/117.6.1357

N. J. Lake, M. J. Bird, P. Isohanni, and A. Paetau, Leigh Syndrome, Journal of Neuropathology & Experimental Neurology, vol.74, issue.6, pp.482-492, 2015.
DOI : 10.1097/NEN.0000000000000195

R. N. Mandler, Neuromyelitis optica ??? Devic's syndrome, update, Autoimmunity Reviews, vol.5, issue.8, pp.537-543, 2006.
DOI : 10.1016/j.autrev.2006.02.008

S. Vucic, Facial onset sensory and motor neuronopathy (FOSMN syndrome): a novel syndrome in neurology, Brain, vol.129, issue.12, pp.3384-3390, 2006.
DOI : 10.1093/brain/awl258
URL : https://academic.oup.com/brain/article-pdf/129/12/3384/743025/awl258.pdf

M. T. Hu, C. M. Ellis, A. Al-chalabi, P. N. Leigh, and C. Shaw, Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.65, issue.6, pp.950-951, 1998.
DOI : 10.1136/jnnp.65.6.950

L. C. Wijesekera, Natural history and clinical features of the flail arm and flail leg ALS variants, Neurology, vol.72, issue.12, pp.1087-1094, 2009.
DOI : 10.1212/01.wnl.0000345041.83406.a2

P. Gambetti, A novel human disease with abnormal prion protein sensitive to protease, Annals of Neurology, vol.3, issue.6, pp.697-708, 2008.
DOI : 10.1017/CBO9781139087131
URL : http://onlinelibrary.wiley.com/doi/10.1002/ana.21420/pdf

G. G. Kovacs, Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity?, Acta Neuropathologica Communications, vol.1, issue.1, p.72, 2013.
DOI : 10.1016/S0002-9440(10)63291-9

S. Mead, A Novel Prion Disease Associated with Diarrhea and Autonomic Neuropathy, New England Journal of Medicine, vol.369, issue.20, pp.1904-1914, 2013.
DOI : 10.1056/NEJMoa1214747
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863770/pdf

M. E. Bruce, Transmissions to mice indicate that " new variant " CJD is caused by the BSE agent, Nature, vol.389, issue.6650, pp.498-501, 1997.
DOI : 10.1038/39057

J. Montag, W. Schulz-schaeffer, A. Schrod, G. Hunsmann, and D. Motzkus, Asynchronous Onset of Clinical Disease in BSE-Infected Macaques, Emerging Infectious Diseases, vol.19, issue.7, pp.1125-1127, 2013.
DOI : 10.3201/eid1907.120438

C. Herzog, Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection, The Lancet, vol.363, issue.9407, pp.422-428, 2004.
DOI : 10.1016/S0140-6736(04)15487-1

N. Lescoutra-etchegaray, Evaluation of the protection of primates transfused with variant Creutzfeldt-Jakob disease-infected blood products filtered with prion removal devices: a 5-year update, Transfusion, vol.71, issue.3, pp.1231-1241, 2015.
DOI : 10.1001/jamaneurol.2013.5378

E. E. Comoy, Atypical BSE (BASE) Transmitted from Asymptomatic Aging Cattle to a Primate, PLoS ONE, vol.3, issue.8, p.3017, 2008.
DOI : 10.1371/journal.pone.0003017.s002
URL : https://doi.org/10.1371/journal.pone.0003017

F. Gray, Neuronal Apoptosis in Creutzfeldt-Jakob Disease, Journal of Neuropathology and Experimental Neurology, vol.58, issue.4, pp.321-328, 1999.
DOI : 10.1097/00005072-199904000-00002

A. Barret, Evaluation of Quinacrine Treatment for Prion Diseases, Journal of Virology, vol.77, issue.15, pp.8462-8469, 2003.
DOI : 10.1128/JVI.77.15.8462-8469.2003

M. H. Groschup and A. Buschmann, Rodent models for prion diseases, Veterinary Research, vol.77, issue.4, p.32, 2008.
DOI : 10.1051/vetres:2008008
URL : https://hal.archives-ouvertes.fr/hal-00902921

J. Y. Douet, Detection of Infectivity in Blood of Persons with Variant and Sporadic Creutzfeldt-Jakob Disease, Emerging Infectious Diseases, vol.20, issue.1, pp.114-117, 2014.
DOI : 10.3201/eid2001.130353

C. Lacroux, Preclinical Detection of Variant CJD and BSE Prions in Blood, PLoS Pathogens, vol.2, issue.4, p.1004202, 2014.
DOI : 10.1371/journal.ppat.1004202.s001

C. Feraudet, Screening of 145 Anti-PrP Monoclonal Antibodies for Their Capacity to Inhibit PrPSc Replication in Infected Cells, Journal of Biological Chemistry, vol.280, issue.12, pp.11247-11258, 2005.
DOI : 10.1074/jbc.M407006200

J. P. Langeveld, Rapid and discriminatory diagnosis of scrapie and BSE in retro-pharyngeal lymph nodes of sheep, BMC Veterinary Research, vol.2, issue.1, p.19, 2006.
DOI : 10.1186/1746-6148-2-19

J. M. Wilham, Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays, PLoS Pathogens, vol.69, issue.12, p.1001217, 2010.
DOI : 10.1371/journal.ppat.1001217.s001

J. Valette, B0 homogeneity throughout the monkey brain is strongly improved in the sphinx position as compared to the supine position, Journal of Magnetic Resonance Imaging, vol.8, issue.3, pp.408-412, 2006.
DOI : 10.1002/jmri.20511